Defined herpes simplex virus type 1 (HSV-1) mutants KOS/1 and KOS/62 (positive and negative, respectively, for latency-associated transcripts [ILATs]) express the Escherichia coli 13-galactosidase gene during latency. These mutants were employed to assess the functions of the latency-associated transcription unit on establishment and maintenance of and reactivation from the latent state. It was found that in the trigeminal ganglia, the frequencies of hyperthermia-induced reactivation of KOS/62 and an additional LATs-mutant (KOS/29) were reduced by at least 80%c. Quantification of latently infected neurons expressing the 13-Gal gene revealed that the LATs-mutant KOS/62 established -80%o fewer latent infections in the trigeminal ganglia than did KOS/1 (LATs+). This reduction in establishment which is evident in the trigeminal ganglia could account for the reduced frequency of reactivation from this site. In striking contrast, both LATsmutants reactivated with wild-type frequencies from lumbosacral ganglia. Quantification of (-Gal-positive neurons at this site revealed that KOS/62 established as many as or more latent infections than the LATs+ virus, KOS/1. Colocalization of HSV antigen and 13-Gal suggested that the decreased establishment by LATsmutants in trigeminal ganglia was the result of inefficient viral shutoff. Thus, one function of the HSV-1 LATs transcription unit is to promote the establishment of latency in trigeminal but not lumbosacral ganglia. Such a function may be relevant to understanding the distinct clinical recurrent disease patterns of HSV-1 and HSV-2.
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It has been well documented that the latency-associated transcription unit is the single region of the herpes simplex virus (HSV) genome which produces a detectable RNA during latency (4-6, 20, 26, 33, 36, 38, 40, 44, 45) . The precise functional significance of transcriptional activity from this region in the establishment, maintenance, and reactivation phases of latent infection is still unclear. Data generated from studies utilizing various LATs-mutants in animal model systems have demonstrated that the LATs transcription unit is not an absolute requirement for any of these aspects of latency (15, 17, 22, 27, 35, 37) , with the possible exception of induced reactivation in vivo (14) . In the study described in reference 14, an LATs-mutant reactivated significantly less frequently by induction via iontophoresis of epinephrine in the rabbit eye model, although spontaneous virus shedding and reactivation in cocultivated ganglia in vitro were not affected (14) . Additionally, the finding reported by several investigators that LATs-mutants reactivate with delayed kinetics in cocultivation studies has been taken as evidence for a reactivation function of LATs (22, 37) . However, a clear interpretation of this finding is difficult since others have reported normal reactivation kinetics in this system with LATs mutants (2, 16, 17, 35) .
A recent study has demonstrated that the major 2-kb transcript from the LATs region is actually a stable intron which is antisense to the immediate-early transcription factor ICPO and that the intron can function to down regulate ICPO production in transient assays (10) . These findings suggest a possible role in establishment of latency. While the * Corresponding author.
LATs transcript (7, 19, 46, 47) and intron have also been detected during lytic infection of cultured cells, no effect of these low levels of the intron on ICPO expression could be detected (7) . The LATs promoter has been shown to contain neuron-specific promoter elements (1, 7, 47) , and thus an increased level of the LATs intron could result in the down regulation of ICPO in this cell type during the establishment of latency.
Because the HSV genome cannot be detected in situ in latently infected tissues, only hybridization methods on DNA extracted from ganglia have been employed to quantitatively evaluate establishment by LATs-mutants (14, 22, 35) . From those studies, it was concluded that LATsviruses established an equivalent amount of latency. However, the methods are not sensitive enough to detect HSV sequences in all ganglia known to be latently infected (14) . Thus, to date, the method used to estimate latency established by LATs-mutants must be considered semiqualitative and inadequate for quantitation of the number of latently infected neurons.
The availability of LATs+ and LATs-mutants in which the LATs promoter drives the Eschenchia coli 3-galactosidase gene has allowed the direct comparison of the relative number of latent infections established by these mutants. In addition, development of the hyperthermia induction procedure (34a) has provided a system with which to examine the induced reactivation frequencies of these mutants in both trigeminal and lumbosacral ganglia in vivo in the absence of spontaneous reactivation events. The phenotypes of LATs-viruses were dramatically different depending on the anatomical site of latency. That is, the induced reactivation frequency of the LATs-mutants from trigeminal ganglia was reduced by nearly an order of magnitude.
Surprisingly, the induced reactivation frequency of the LATs-mutants from lumbosacral ganglia was indistinguishable from that of the wild type. This is the first report to demonstrate a phenotype for the LATs transcription unit dependent on the anatomical location of latency. (8) . This deletion removes the CREB binding site (23) , the TATA, and the transcriptional start site (8) . The virus produces no detectable LATs (8) . KOS/62 is an LAT-mutant in which HSV type 1 (HSV-1) sequences from the SaclI site at 118,842 bp to the HpaI site at 120,466 bp of the internal long repeat and the corresponding region of the terminal long repeat were deleted and replaced with the E. coli 13-Gal gene. Both copies of the LATs are disrupted in this virus (reference 11 and this report). Thus, the LATs promoter drives 1-Gal in this virus. In KOS/1, a large region of the LATs promoter was placed in front of the 1-Gal gene and inserted into the EcoRV site at 97,646 bp in the glycoprotein C locus. This resulted in the disruption of glycoprotein C and the expression of 1-Gal during latency in an LATs+ virus (12) . The genomic structures of these viruses are shown schematically in Fig. 1 . All restriction enzyme sites are referred to as the corresponding positions in the published HSV-1 sequence of strain 17 syn+ (for a review, see reference 24).
Southern blot analysis of viral genomic structures. In order to confirm that the virus reactivating in the cultures had the expected genomic structure, total infected cell DNA was isolated, digested with various restriction endonucleases according to the manufacturers' (Bethesda Research Laboratories, Promega, and New England Biolabs) recommendations, electrophoresed in agarose gels, transferred to nitrocellulose, and probed with various nick translated 32P-labeled probes as described previously (3, 9) .
Quantitative PCR detection of HSV DNA present in latently infected ganglia. Quantitative polymerase chain reaction (PCR) was carried out precisely as previously described except that both trigeminal ganglia from each mouse were pooled for DNA extraction (18) . Briefly, mice were infected as described above, and DNA was extracted from the ganglia at 30 days p.i. Tissues (18) except that additional washes at 52°C were performed. Blots were exposed to X-ray film (Kodak) for photography and exposed in a Molecular Dynamics PhosphorImager and analyzed with ImageQuant software (Molecular Dynamics) for quantification.
Acute replication kinetics. The kinetics of acute replication of these viruses was determined as described previously (42) . In brief, 4 Colocalization of 13-Gal and HSV antigen. Ganglia from the preceding section from days 3, 4, and 6 p.i. were rinsed in PBS and postfixed in 4% paraformaldehyde for 3 h. The subsequent dehydration, paraffin embedding, and immunoperoxidase staining for HSV antigens were as described in reference 34a. Serial sections (10 ,um thick) were cut and systematically examined so that assessment of antigen could be made at multiple levels in each neuron.
RESULTS
The following experiments were designed to confirm and extend previous studies examining the function of the LATs transcription unit in establishment, maintenance, and in vivo reactivation both of these ganglionic sites was now possible with the hyperthermia induction procedure described in reference 34a.
Since LATs transcripts have been detected at relatively constant levels in ganglionic neurons during latency, the LATs promoter has been considered to be continually active in latently infected cells (for a review, see reference 39).
Therefore, LATs+ (KOS/1) and LATs-(KOS/62) mutants which contained n-Gal controlled by the LATs promoter were utilized so that latently infected cells could be detected histochemically and counted. The establishment efficiency of the LATs-and LATs+ mutants could thus be compared directly at the cellular level. The feasibility of this approach has been demonstrated in a previous study in which the 3-Gal gene was inserted behind the LATs promoter in an LATs-mutant (15) . Although quantitative analysis of latency was not done in that study, latently infected neurons were identified histochemically as "blue cells." Characterizatiop of HSV-1 LATs+ and LATs-mutants. The genomic structures of KOS/1 (LATs+) and KOS/62 and has been previously described (8) (Fig. 3A) . Both LATs-viruses, however, reactivated with significantly deurn-a J. VIROL. layed kinetics (P < 0.005; Student's t test), a finding reported by others (22, 37) . These results clearly demonstrated that 100% of the animals were latently infected by these inoculation procedures.
Induced reactivation in vivo. To date, the only phenotypic difference of an LATs-mutant demonstrated in vivo has been a decreased frequency of reactivation induced by iontophoresis of epinephrine in the rabbit eye model (14) . To examine whether the reactivation frequency of LATs-mutants would also be reduced in mice when the hyperthermia induction procedure was used, the reactivation system described in reference 34a was employed. Latently infected mice were subjected to hyperthermia as described and were sacrificed 24 were fixed and assayed for enzyme activity in situ. To avoid the inaccuracy inherent in generating a number from sectioned ganglia, the histochemical assay was performed with whole ganglia which were subsequently cleared and pressed.
Quantitative This inoculation procedure resulted in an increase in the number of latently infected (,-Gal-positive) neurons in KOS/ 1-infected ganglia (average, 61.5; range, 17 to 125), which could explain the increase in reactivation frequency observed. KOS/62-infected animals also had an increase in the number of latently infected cells compared with animals inoculated via bilateral corneal scarification alone (average, 23.2; range, 16 to 33). However, this number was still 64% less than the number of latently infected neurons seen with KOS/1 and was still far less than the predicted number of latently infected neurons required for reactivation in this model (Fig. 6B) . These data confirmed results from our first set of experiments, indicating that the LATs function to facilitate the establishment of latency. Because the number of latently infected neurons detected in KOS/62-infected mice was still very low, it was not possible to determine whether LATs also functioned directly in reactivation.
Analysis of HSV DNA present in latently infected ganglia. Several laboratories have previously reported that the LATs locus plays no role during the establishment of latency (16, 17, 22, 35 hybridized to a 32P-labeled oligonucleotide specific for the HSV TK gene product (top panels) and then stripped and hybridized to a probe specific for the product of the mouse adipsin gene (bottom panels). The left panels are a reconstruction of known amounts of HSV genomes in 100 ng of mouse DNA. The right panels show results with 100 ng of latently infected ganglionic DNA. Autoradiograms were produced for photographic purposes. The blots were also scanned on a Molecular Dynamics Phosphorlmager, and counts per minute (CPM) present in the bands were determined by using ImageQuant software (table at right).
ganglia by slot blot hybridization. We next sought to determine whether the amount of HSV DNA present in latently infected ganglia was correlated with the number of i-Galpositive neurons present. The purpose of these experiments was twofold: to determine the HSV genome copy number present per LATs promoter-positive neuron, and to gain evidence that some unknown difference in LATs promoter activities between KOS/1 and KOS/62 was not responsible for the observed difference in establishment frequencies identified in trigeminal ganglia as described above.
Initial experiments to quantify HSV DNA present in latently infected ganglia by slot blot hybridization were inconclusive. By preadsorbing the probe employed to a filter saturated with mouse DNA, a specific signal could be obtained at 104 HSV genomes per 1 ,ug of mouse DNA.
Regardless of the infecting strain, 3 x 104 to 2 x 105 HSV genome equivalents per microgram were detected in samples of latently infected ganglia. Although the amount of HSV DNA detected in the ganglia infected with LATs-mutants was often lower than that in the LATs+ samples, the groups overlapped, a result consistent with previous reports by others (22, 35) . However, the level of sensitivity was not sufficient to detect HSV DNA in all latently infected ganglia and not linear enough at this level to unambiguously document a 30 to 60% difference between strains (data not shown). Therefore, the more sensitive approach of quantitative PCR in which both HSV and mouse DNA could be simultaneously quantified was employed (18) .
Pairs of trigeminal ganglia from mice latently infected with KOS(M), KOS/1, or KOS/62 were pooled, and the DNA was extracted and treated precisely as described previously (18) . Results of such an analysis are shown in Fig. 7 Fig. 9 . Blue cells could be detected as early as 2 days p.i. with either virus at both anatomic locations. However, the number detected was low. On day 3, equivalent numbers of blue neurons were seen in trigeminal ganglia from the KOS/1-and KOS/62-infected mice (n = 8 ganglia for each; averages were 163.5 and 193.8, respectively, and ranges were 72 to 225 and 95 to 292, respectively). This was also true of day 4 ganglia, although by this time one ganglion from a mouse infected with KOS/62 had a low number of blue neurons (KOS/1, n = 10, average was 168.2, and range was 77 to 192; for KOS/62, n = 10, average was 157.7, and range was 32 to 304). By day 6, the difference between KOS/1 and KOS/62 observed at 30 days p.i. was readily apparent and statistically very significant (KOS/1, n = 12, average was 197, and range was 103 to 390; (KOS/62, n = 14, average was 90.9, and range was 24 to 152; P = 0.0004, unpaired T test).
As shown in Fig. 10 , many intensely blue neurons with blue axonal processes were present on day 6 in trigeminal and lumbosacral ganglia from both KOS/1-and KOS/62-infected animals. It was evident at this time point that for the trigeminal ganglia, there were far fewer blue neurons in KOS/62-infected ganglia than in ganglia infected with equivalent titers of KOS/1 (Fig. 10A and B) . In contrast, lumbosacral ganglia examined on day 6 from mice inoculated with KOS/1 or KOS/62 were indistinguishable (Fig. 10C and  D) . At both sites by day 15, the intensity of blue was markedly lower and the actual number of blue neurons had decreased in parallel in KOS/1-and KOS/62-infected animals. This decrease in the number of blue neurons continued through day 30. The overall intensity also further diminished, the diffuse cytoplasmic staining present earlier in most cells was no longer apparent, and a punctate distribution of the enzyme within the positive neurons was most common.
A most significant finding of this experiment was that equal numbers of p-Gal-positive neurons were seen in trigeminal ganglia infected with either KOS/1 or KOS/62 through 3 to 4 days p.i., after which time the numbers began to diverge. Clearly then, both of these viruses reached the ganglia and expressed the LATs promoter in equivalent numbers of neurons early after infection. These data suggested that transcription from the LATs locus exerted its influence early during acute infection (between days 3 and 6) and might be involved in the switch from acute infection to latency. If this was the case, one would predict that with LATs+ strains such as KOS/1, expression of the LATs promoter would be associated with a shutoff of viral protein synthesis on days 3 to 4 p.i. and that two populations of cells would be detected at this time: one expressing LATs and one expressing viral antigen. In contrast, with KOS/62 (LATs-), expression of the LATs promoter would colocalize with HSV antigen in neurons. Further, such a difference between these strains should be detectable in trigeminal but not lumbosacral ganglionic neurons.
Immunohistochemical staining for HSV antigens was combined with detection of 1-Gal to examine the relationship between LATs promoter activity and antigen production. Animals were inoculated as above with either KOS/1 or KOS/62, and relevant ganglia were harvested and processed on days 3 and 4 p.i. Serial sections were examined with a 100x oil immersion objective, and care was taken to examine several levels of each blue neuron for the presence of HSV antigen. It was found that in all cases, there were 5 to 10 times more antigen-positive neurons than neurons expressing 1-Gal. Therefore, the LATs promoter was active only in a small subset of infected neurons. HSV antigen could be detected in some of the blue neurons. It was of particular interest that compared with results for ganglia infected with KOS/1, there was a significantly higher frequency of colocalization of 13-Gal and HSV antigen in KOS/62-infected trigeminal but not lumbosacral ganglia (summarized in Fig. 9) .
In KOS/62-infected trigeminal ganglia on day 3 p.i., 47% Fig. 3B , virus in 100% of the ganglia from animals infected with both LATs+ and LATs-mutants reactivated by explant cocultivation at 140 days p.i. This is in agreement with a previous report examining the long-term maintenance of an LATs-mutant (35) . However, the kinetics of reactivation of 
DISCUSSION
The LATs are a related group of RNA molecules found in the nucleus of a population of neurons in latently infected ganglia (4, 5, 20, 26, 33, 38, 40, 44, 45) . Because this is the only region of the HSV genome transcriptionally active during latency, a great deal of effort has been placed in determining the functional significance of the LATs or protein products from this locus. The LATs RNAs have been mapped on the viral genome by in situ hybridization of latently infected ganglia by using a series of small oligonucleotide probes (45) . The promoter for the LATs has been identified some 700 bp upstream from the start of the LATs (8) . This has led to the demonstration that the LATs are a metabolic byproduct of a larger transcription unit (7, 10 (2) and dorsal root ganglia (35) and rabbit trigeminal ganglia (14) . The reduced reactivation kinetics observed in the studies above has been interpreted as a reduced ability of LATs-mutants to reactivate. Our data suggest that this phenomenon may be explained at least in part by reduced establishment by such mutants.
There has been only one report of in vivo reactivation studies with an LATs mutant. After iontophoresis of epinephrine in the rabbit eye model, an LATs-mutant was not induced to reactivate above the background of spontaneous virus shedding. The authors concluded that the LATs locus enhanced induced reactivation but were unable to determine whether the LATs were an absolute requirement (14) .
Analysis of these findings is complicated by the fact that it is not possible to quantify the establishment of latency by LATs-mutants on a cellular level. The ability of HSV-1 LATs mutants to establish latent infections has been addressed by indirect measures, including determination of acute viral replication kinetics and quantitation of viral DNA extracted from ganglion tissues (14, 16, 22) . These experiments have led to the general consensus that the LATs locus is not required for establishment of latency (39) . Unfortunately, these methods are not sensitive enough to detect viral DNA in all ganglia known to be latently infected (14) and may not reflect the true amount of biologically active viral DNA present (22 and HSV antigen during the establishment phase of infection demonstrated that the LATs promoter was active in only a small subset of infected neurons. In KOS/1-infected ganglia, the great majority of 3-Gal-positive neurons contained no HSV antigen, a finding consistent in both trigeminal and lumbosacral ganglia. Conversely, in trigeminal ganglia infected with KOS/62, the majority of 1-Gal-positive neurons contained HSV antigen, while in lumbosacral ganglia, the extent of colocalization was similar to that observed with KOS/1. Light microscopic examination indicated that at least some of these 1-Gal-positive, antigen-positive neurons did not survive. These results strongly suggest that viral shutoff in trigeminal neurons is inefficient in the absence of LATs transcription. Thus, we conclude that expression of the HSV-1 LATs locus facilitates establishment of latency in the trigeminal but not the lumbosacral ganglia. The LATs function is not an absolute requirement but serves to greatly increase the number of neurons in which establishment occurs.
In humans, the most common site of HSV-1 latency is the trigeminal ganglia, resulting from primary infection of the oral mucosa. Primary oral-labial infections with HSV-1 recur more frequently than such infections with HSV-2. The converse is also true in that HSV-2 recurrences are much more prevalent than HSV-1 recurrences after primary genital infection (21, 32) . However, to date, specific viral functions which contribute to this ganglionic site-specific behavior have not been identified. This is the first report of an HSV-1 genotype expressed as distinct phenotypes in ganglia at different anatomic locations. This finding emphasizes the importance of considering the anatomic site used for experimental analyses of establishment and reactivation functions of HSV-1 LATs. Furthermore, it suggests the intriguing possibility that the LATs transcription unit may play a role in the clinical recurrence patterns of HSV-1 and HSV-2 in humans.
The fact that the HSV-1 LATs function to enhance establishment in trigeminal but not lumbosacral neurons would seem at first to be a paradox, and it may be that the mouse model breaks down in this regard. However, our findings are consistent with the pattern of recurrent disease in humans if one postulates that the permissiveness of neurons at various ganglionic sites varies and that this permissiveness plays an important role in the progression of a reactivation event to disease recurrence at the body surface. It is very clear that establishment of latency can occur in the absence of LATs or most other HSV gene transcription (15-18, 22, 27, 35, 37) . Therefore, the idea of a default establishment pathway, due to the nonpermissiveness of the neuron, must be entertained. If one postulates that lumbosacral neurons are less permissive than trigeminal neurons,' one could predict that this default pathway might be dominant for HSV-1 and that the effect of the absence of LATs transcription in HSV-1 strains would not be seen in this tissue. Conversely, in more permissive trigeminal neurons the effect would be apparent, as the default pathway would no longer be as dominant.
Neurovirulence is clearly not a prerequisite for the establishment of or reactivation from latency (43) . Therefore, neurovirulence is likely to be titrated by a combination of the requirement to preserve the host and the requirement to replicate in neurons following reactivation to produce recurrent disease. If lumbosacral neurons are less permissive, HSV-2 strains would be predicted to be more neurovirulent than HSV-1 strains. This has long been known to be true (28) (29) (30) (31) . This model would also predict that HSV-1 could establish latency in lumbosacral neurons and, because HSV-1 is less capable of replication in these cells, reactivate without causing apparent disease at the body surface. An additional prediction of this hypothesis is that HSV-2 strains would also carry an establishment function which would be apparent in the normal target tissue. It has recently been reported that HSV-2 also encodes LATs during latency and that the transcription unit is similar to but distinct from that seen in HSV-1 (25) . It will be of great interest to examine the roles of the HSV-2 LATs in establishment and reactivation and compare the phenotypic expression of HSV-2 LATsmutants in trigeminal and lumbosacral ganglia. Such experiments are currently in progress.
Finally, a variety of procedures have been shown to induce the reactivation of HSV-1 experimentally, and these include UV light, superinfection, chemical treatments, iontophoresis of epinephrine, physical trauma, neurectomy (reviewed in reference 34), and transient hyperthermia (34a). It should be emphasized that the interplay of viral and host factors which lead to reactivation and recurrent disease is undoubtedly complex and that the relative importance of any one factor may be dependent on the nature of the induction event and, as demonstrated in this study, the specific ganglionic site of latency.
